OCUL vs OKE · rev $63.7M vs P/E 15, rev $21.70B
Ocular Therapeutix Inc (OCUL) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Ocular Therapeutix Inc (OCUL) is a biotechnology company listed on US.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported OCUL revenue for 2024-12-31 was $63.7M. Net income was -$193.5M. Revenue was up 9.0% from 2023-12-31 to 2024-12-31. OCUL currently screens at market cap $1.76B.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
OCUL currently screens at market cap $1.76B. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the OCUL and OKE stock pages for the full models.
Not investment advice.